• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

髓系白血病的化疗

Chemotherapy of the myeloid leukaemias.

作者信息

Stuart J

出版信息

J R Coll Physicians Lond. 1980 Jan;14(1):36-41.

PMID:7003128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5373205/
Abstract

These advances in chemotherapy and supportive care of the myeloid leukaemias offer substantially improved prospects for the future. At present the intensive treatment of acute and chronic myeloid leukaemia requires the resources of a specialist unit and as many patients as possible should now be referred for diagnostic classification and remission induction. Thereafter, courses of maintenance chemotherapy can be supervised jointly by the referring local physician and the specialist centre. This collaborative approach is to the mutual advantage of the patient, his local clinician, and the specialist centre.

摘要

这些在髓系白血病化疗及支持治疗方面的进展为未来带来了显著改善的前景。目前，急性和慢性髓系白血病的强化治疗需要专科单位的资源，现在应尽可能多地将患者转诊进行诊断分类和缓解诱导。此后，维持化疗疗程可由转诊的当地医生和专科中心共同监督。这种协作方式对患者、其当地临床医生和专科中心都有共同的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644d/5373205/3e8854c062af/jrcollphyslond90307-0041-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644d/5373205/de81a0adba86/jrcollphyslond90307-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644d/5373205/3e8854c062af/jrcollphyslond90307-0041-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644d/5373205/de81a0adba86/jrcollphyslond90307-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644d/5373205/3e8854c062af/jrcollphyslond90307-0041-a.jpg

相似文献

1
Chemotherapy of the myeloid leukaemias.髓系白血病的化疗
J R Coll Physicians Lond. 1980 Jan;14(1):36-41.
2
A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Biomedicine. 1973 May;18(3):192-8.
3
Intensive chemotherapy for acute myelogenous leukemia.急性髓性白血病的强化化疗
Ann Intern Med. 1981 Jun;94(6):753-7. doi: 10.7326/0003-4819-94-6-753.
4
D.A.T. (daunorubicin, cytarabine, 6-thioguanine) in acute myeloid leukaemia.
Lancet. 1978 Jun 24;1(8078):1360-1. doi: 10.1016/s0140-6736(78)92433-9.
5
Progress in acute myelogenous leukemia.
Cancer Treat Rep. 1981;65 Suppl 4:87-92.
6
High remission-induction rate in acute myeloid leukaemia.
Lancet. 1977 Mar 5;1(8010):497-9. doi: 10.1016/s0140-6736(77)91366-6.
7
Acute myelogenous leukemia: morphologic classification and response to therapy.急性髓细胞白血病：形态学分类及对治疗的反应
Leuk Res. 1979;3(3):171-3. doi: 10.1016/0145-2126(79)90015-8.
8
The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.硫鸟嘌呤对柔红霉素、阿糖胞苷和泼尼松联合治疗成人急性白血病的疗效。芬兰白血病研究组。
Scand J Haematol. 1979 Aug;23(2):124-8.
9
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia.
Med Pediatr Oncol. 1979;6(3):261-77. doi: 10.1002/mpo.2950060311.
10
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Bull Cancer. 1974 Jul-Sep;61(3):411-8.

本文引用的文献

1
Acute promyelocytic leukemia: results of treatment by daunorubicin.
Blood. 1973 Apr;41(4):489-96.
2
A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models.
Blood. 1976 Dec;48(6):795-807.
3
Developmental therapy in adult acute leukemia.成人急性白血病的发育治疗
Arch Intern Med. 1976 Dec;136(12):1417-21.
4
Marrow transplantation for acute nonlymphoblastic leukemia in first remission.
N Engl J Med. 1979 Sep 13;301(11):597-9. doi: 10.1056/NEJM197909133011109.
5
Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin.
N Engl J Med. 1979 Feb 15;300(7):333-7. doi: 10.1056/NEJM197902153000702.
6
Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.急性非淋巴细胞白血病：在细胞中的表达局限于粒细胞和单核细胞分化。
N Engl J Med. 1979 Jul 5;301(1):1-5. doi: 10.1056/NEJM197907053010101.
7
Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation.冷冻保存的外周血细胞在慢性粒细胞白血病转化患者中作为自体移植物发挥作用。
Br Med J. 1979 May 19;1(6174):1310-3. doi: 10.1136/bmj.1.6174.1310.
8
Clonal identification in acute lymphoblastic leukemia.急性淋巴细胞白血病中的克隆鉴定
Blood. 1979 May;53(5):892-8.
9
Infiltration of central nervous system in adult acute myeloid leukaemia.成人急性髓系白血病中枢神经系统浸润
Br Med J. 1979 Jan 27;1(6158):227-9. doi: 10.1136/bmj.1.6158.227.
10
Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).采用强化治疗方案（L-5方案）治疗费城染色体阳性慢性粒细胞白血病的结果
Blood. 1979 Mar;53(3):375-95.